- New shipment brings U.S.-bilaterally donated doses to Nigeria to over 7.5 million
The U.S. Mission in Nigeria on Thursday announced the arrival of 3,577,860 doses of Pfizer vaccine for the public health and benefit of the Nigerian people through COVAX, the worldwide initiative ensuring equitable access to COVID-19 vaccines.
A statement by the U.S. Mission in Nigeria said that the new shipment arrived at the Nnamdi Azikiwe International Airport in Abuja on Thursday October 14 and “will bring the total number of U.S.-bilaterally donated doses to Nigeria to over 7.5 million.
“The U.S. also contributed to the first multilateral donation of AstraZeneca vaccine in March 2021. Overall, COVAX has provided Nigeria with over 10 million doses to date.
“Safe and effective vaccines are our best tool to ending the pandemic. The United States has pledged to purchase and donate 1.1 billion COVID-19 vaccine doses worldwide, and to date has delivered more than 180 million doses to more than 100 countries.”
The statement added that the U.S. government’s continued efforts to provide vaccines to African Union (AU) member countries helps fulfill President Biden’s pledge when he said: “The United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home. We are sharing these vaccines to save lives and to lead the world in bringing an end to the pandemic.”
It noted that the “vaccine donations are part of the U.S. government’s continued partnership with the Government of Nigeria in combatting COVID-19. To date, the U.S. government has provided $130 million of support to Nigeria’s Ministry of Health and Presidential Steering Committee on COVID-19.
“The U.S. government is looking forward to continued coordination with Nigeria and its Center for Disease Control to deliver life-saving doses across the country through the COVAX initiative.”
